Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Amanam I, Ngo D, Pullarkat V, Aldoss I, et al. Leuk Lymphoma 2022;63:3268-3270.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amanam I, Ngo D, Pullarkat V, Aldoss I, et al. Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Leuk Lymphoma 2022;63:3268-3270.
PMID: 36016465